Chemoinformaics analysis of Quercetin-3-O-Beta-L-Rhamnoside
| Molecular Weight | 448.38 | nRot | 3 |
| Heavy Atom Molecular Weight | 428.22 | nRig | 24 |
| Exact Molecular Weight | 448.101 | nRing | 4 |
| Solubility: LogS | -4.03 | nHRing | 2 |
| Solubility: LogP | 0.819 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 57.2279 |
| nHD | 7 | BPOL | 26.1401 |
| QED | 0.276 |
| Synth | 4.008 |
| Natural Product Likeliness | 2.165 |
| NR-PPAR-gamma | 0.953 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.607 |
| HIA | 0.534 |
| CACO-2 | -6.142 |
| MDCK | 0.00000655 |
| BBB | 0.012 |
| PPB | 0.895246 |
| VDSS | 0.839 |
| FU | 0.110999 |
| CYP1A2-inh | 0.098 |
| CYP1A2-sub | 0.064 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.05 |
| CYP2c9-inh | 0.043 |
| CYP2c9-sub | 0.5 |
| CYP2d6-inh | 0.141 |
| CYP2d6-sub | 0.194 |
| CYP3a4-inh | 0.075 |
| CYP3a4-sub | 0.018 |
| CL | 6.373 |
| T12 | 0.8 |
| hERG | 0.011 |
| Ames | 0.82 |
| ROA | 0.094 |
| SkinSen | 0.181 |
| Carcinogencity | 0.068 |
| EI | 0.173 |
| Respiratory | 0.041 |
| NR-Aromatase | 0.917 |
| Antiviral | Yes |
| Prediction | 0.85892 |